Home
Resource
Structure-function analysis of the non-helicase domain of Sgs1, the Bloom Syndrome ortholog from Saccharomyces cerevisiae
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(19.42 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Tuberty-Vaughan, Lynda. Structure-function analysis of the non-helicase domain of Sgs1, the Bloom Syndrome ortholog from Saccharomyces cerevisiae. Retrieved from https://doi.org/doi:10.7282/T3TM79DH

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleStructure-function analysis of the non-helicase domain of Sgs1, the Bloom Syndrome ortholog from Saccharomyces cerevisiae
NameTuberty-Vaughan, Lynda (author); Brill, Steven J (chair); Vershon, Andrew (co-chair); Mckim, Kim (co-chair); Rutgers University; Graduate School - New Brunswick
Date Created2011
Other Date2011-05 (degree)
SubjectCell and Developmental Biology, Saccharomyces cerevisiae, Genomics, Oncogenic DNA viruses
Extentix, 76 p. : ill.
DescriptionBloom’s Syndrome (BS) is a rare human disease characterized by genome instability and cancer predispostion. The gene mutated in BS, BLM, encodes a member of the RecQ family of DNA helicases. BLM is unique among this family because it is the only RecQ member conserved in unicellular eukaryotes. Apart from the DNA helicase domain, BLM/SGS1 orthologs contain a poorly characterized N-terminal domain of about 650 amino acids (aa). In yeast, this domain (Sgs1 1-652) is known to be physiologically important although it’s only known roles are to bind Top3 and Rmi1 through its N-terminal 100 aa, and in vitro single-strand DNA (ssDNA) binding, ssDNA annealing and strand exchange (SE) activities, through its SE domain (Sgs1 103-323) My research consisted of structure/function analyses of Sgs1 in its poorly characterized N-terminus of aa 323-652 and I found a domain that is important to Sgs1’s function. I interrogated this region by doing systematic deletions and tested these sgs1 mutants for complementation of synthetic lethality. The allele with the smallest deletion that did not complement sgs1slx4 synthetic lethality was found to be sgs1-∆386-621, and the allele with the smallest deletion that did not complement sgs1slx5, was found to be sgs1-∆500-621. I found that sgs1-∆386-621 is physiologically important also through the Top3 slow growth assay. Furthermore I believe that the difference in results between sgs1slx4 and sgs1slx5 will prove significant and warrants further investigation. I also used a BLM/GCN4 chimera where the SE domain was replaced with the coiled coil GCN4, and again tested alleles with systematic deletions within aa 323-652 in synthetic lethality assay. I found the smallest essential domain to be sgs1/gcn4-∆500-621 in the sgs1slx4 background, and interestingly the same deletion in sgs1-∆500-621 did grow weakly and complemented synthetic lethality. Therefore I postulate there is some interaction between the SE domain and aa 500-621 that could be physiologically important and again warrants further investigation.
NoteM.S.
NoteIncludes bibliographical references
Noteby Lynda Tuberty-Vaughan
Genretheses, ETD graduate
Persistent URLhttps://doi.org/doi:10.7282/T3TM79DH
Languageeng
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024